Huma

29/08/2023

We are so excited to reveal our newest collaboration with…..

🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁

Google Cloud!

We are exploring the use of Google’s GenAI tools, including Med-PaLM 2 to improve patient engagement and boost the clinical capacity of healthcare professionals.

Read more here: http://www.huma.com/resources/google-cloud-healthcare-gen-ai-med-palm2?utm_medium=social&utm_source=facebook&utm_campaign=fy23_q3_multichannel+ai+campaign_all_huma&utm_content=press_release

25/08/2023

📢 Get ready for some big news! 🚀

Stay connected as we shake up the world of digital health by pushing the boundaries of technology, bringing you closer to a future of better care and research. 🩺📲

Mark your calendars – this is one update you won't want to miss! ⏰

01/05/2023

The effects of pollution and climate change are not evenly distributed, with low- and middle-income countries being the most vulnerable. More than 90% of deaths caused by air pollution occur in these countries.

To achieve the World Health Organisation’s vision of Health for All, we must tackle these inequities head on.

At Huma, we're committed to reducing health inequities and promoting sustainable practices to ensure that everyone has access to a healthy future.

Read more about our approach to achieving health equity here: https://www.huma.com/resources/earth-day-planetary-health-is-key-to-achieving-global-wellness?utm_medium=social&utm_source=linkedin&utm_campaign=huma&utm_content=earth_day

To mark its 75th anniversary, the World Health Organisation has made Health for All the focus for this year. This Earth Day, we are looking at how planetary health is an essential component of reaching that goal.

27/04/2023

Did you know that pollution is responsible for one in six deaths globally? Air pollution alone caused almost 75% of these deaths in 2019.

At Huma, we believe that everyone should have an opportunity to attain their highest level of health. That's why we work with governments, hospital groups, universities, life science and technology companies to reduce health inequities and promote sustainable practices.

Read more about the link between planetary and human health here: https://www.huma.com/resources/earth-day-planetary-health-is-key-to-achieving-global-wellness?utm_medium=social&utm_source=linkedin&utm_campaign=huma&utm_content=earth_day

To mark its 75th anniversary, the World Health Organisation has made Health for All the focus for this year. This Earth Day, we are looking at how planetary health is an essential component of reaching that goal.

22/04/2023

Today is Earth Day!

Now in its 75th year, the World Health Organisation's focus for 2023 is Health for All.

Our Chief of Staff Constanza Di Gennaro discusses the crucial role of planetary health in achieving global wellness on our blog.

Read more: https://www.huma.com/resources/earth-day-planetary-health-is-key-to-achieving-global-wellness?utm_medium=social&utm_source=facebook&utm_campaign=huma&utm_content=earth_day

30/03/2023

Our new Class IIb certification means you can provide more proactive, predictive and smarter patient care.

Our software as a medical device ( ) generates personalised insights from a patient's medical history, symptoms, digital biomarkers and current condition to accurately diagnose even high-acuity conditions.

We help clinical teams formulate treatment plans, recommend medications, proactively monitor patients’ progress and stay informed of any changes or issues that arise.

Learn more about our platform’s capabilities here: https://hubs.ly/Q01Jvzss0

Huma Therapeutics, a leading global digital health company, today announced that it has become the only company in the world to receive EU MDR 2017/745 Class IIb certification for a disease agnostic Software as a Medical Device (SaMD).

24/03/2023

Software as a medical device (SaMD) should be properly regulated to ensure patient safety, but only 7% of digital health ventures produce clinical trial data, and fewer than one in 10 digital health ventures make regulatory filings.

With our recent EU MDR Class IIb certification, Huma is changing the game. On the Huma blog, our Global Director of QARA Rudolf Wagner explains:

- What EU MDR Class IIb certification is
- How Huma achieved Class IIb
- What Class IIb means for existing and future users of Huma's platform

Read here: https://hubs.la/Q01J2GrV0

23/03/2023

It’s a big day for Huma! We have become the first and only company to be awarded EU MDR Class IIb certification for a disease-agnostic SaMD platform.

This means our platform can now monitor patients of all ages with any condition - including infants and in pregnancy - and can connect with a range of external devices, such as heart rate, blood sugar monitors or smart inhalers.

We can also support clinicians to manage serious and critical conditions such as heart failure, COPD exacerbations, surgical recovery, cancer, immunodeficiency and asthma attacks.

This is a huge milestone for Huma and for the healthcare industry. Thank you to everyone who made it happen.

Read more about Class IIb and what it means for healthcare providers and patients here: https://hubs.la/Q01HSdnN0

23/11/2022

Life at Huma 💛

07/11/2022

Clare, Marta and Dennis from our DCT team represented Huma at OCT Nordics last week.

Now they’re in Amsterdam for Clinical Trials Europe (booth 75) showing everyone how to conduct fully remote or hybrid clinical trials that improve protocol adherence, engagement, retention and diversity.

We’re so proud of our team’s dedication to sharing how we’re accelerating digital-first care and research.